- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 26.11. | Sarepta pays $500M cash for rights to 'multiple potential blockbusters' from Arrowhead | ||
| 26.11. | Guardant Health awarded $292M in false advertising suit against Natera | ||
| 26.11. | Amgen's monthly obesity drug matches competition in phase 2, but investors are unimpressed | ||
| 26.11. | Cash-strapped Medigene lays off 40% of staff, pauses plan to enter clinic | ||
| 26.11. | Roche inks $1.5B Poseida buyout, betting off-the-shelf CAR-Ts will democratize access to cell therapies | ||
| 26.11. | Alector lays off 17% of staff after AbbVie-partnered Alzheimer's asset fails phase 2 | ||
| 26.11. | Roche's TIGIT prospect fails another phase 3 lung cancer test | ||
| 25.11. | Abbott completes first-in-human procedures for balloon-expanded TAVR heart implant | ||
| 25.11. | AI model matches patients to trials almost as accurately as humans: study | ||
| 25.11. | Boston Scientific picks up chemotherapy infusion implant maker aimed at inoperable liver tumors | ||
| 25.11. | Advantage Therapeutics spins out mRNA tech with initial focus on metabolic disease | ||
| 25.11. | Gilead buys HIV vaccine from Spanish biotech following success in clinical collab | ||
| 25.11. | Biohaven fails phase 3 SMA test but plans talks with FDA, plots move into obesity | ||
| 25.11. | China's HanxBio plans Hong Kong IPO to fund phase 2 solid tumor trial | ||
| 25.11. | Cassava flunks phase 3 Alzheimer's test, triggering early end of 2nd trial and stock crash | ||
| 22.11. | Engineered yeast cells deliver PD-1 inhibitors that shrink intestinal tumors in mice | ||
| 22.11. | Halozyme withdraws $2B bid for Evotec after German biotech was 'unwilling to engage' | ||
| 22.11. | After ALS trial misses mark, Seelos has filed for bankruptcy | ||
| 22.11. | Chutes & Ladders-Pfizer replaces retiring CSO with cancer chief | ||
| 22.11. | AstraZeneca cans phase 2 opioid use disorder drug over interaction with common antifungal med | ||
| 22.11. | Neurogene reports death of Rett patient left in critical condition by high dose of gene therapy | ||
| 21.11. | Flagship-backed Sonata says sayonara to CEO, trims crew by 20 staffers | ||
| 21.11. | Philips raises curtain on next-gen helium-sealed MRI scanner | ||
| 21.11. | Pyxis' shares tumble after early ADC readout in solid tumors fails to spark inspiration: analyst | ||
| 21.11. | After ProfoundBio buy, Genmab open to more M&A if it makes 'strategic sense,' CFO says |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
